We are live on ! Find out more
WSCM

Wellington Shields Capital Management Portfolio holdings

AUM $666M
1-Year Est. Return 45.43%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+45.43%
3 Year Est. Return
+80.5%
5 Year Est. Return
+105.84%
10 Year Est. Return
+356.31%
AUM
$644M
AUM Growth
+$35.1M
Cap. Flow
+$6.76M
Cap. Flow %
1.05%
Top 10 Hldgs %
36.49%
Holding
362
New
41
Increased
85
Reduced
99
Closed
31

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.37M
2
AES icon
AES
AES
+$1.69M
3
META icon
Meta Platforms (Facebook)
META
+$1.48M
4
WP
Worldpay, Inc.
WP
+$1.32M
5
APOG icon
Apogee Enterprises
APOG
+$1.19M

Top Sells

Rank Stock Value
1
LNCE
Snyders-Lance, Inc.
LNCE
+$2.23M
2
NKE icon
Nike
NKE
+$1.39M
3
GIMO
Gigamon Inc.
GIMO
+$1.3M
4
TRIP icon
TripAdvisor
TRIP
+$1.18M
5
RRC icon
Range Resources
RRC
+$1.04M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.2%
2 Industrials 11.04%
3 Technology 9.96%
4 Healthcare 9.35%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
276
Ecolab
ECL
$79.9B
$309K 0.05%
+2,300
New +$306K
UPS icon
277
United Parcel Service
UPS
$88.9B
$305K 0.05%
2,562
DHR icon
278
Danaher
DHR
$144B
$302K 0.05%
+3,667
New +$298K
FLOT icon
279
iShares Floating Rate Bond ETF
FLOT
$10.3B
$302K 0.05%
5,950
RHT
280
DELISTED
Red Hat Inc
RHT
$300K 0.05%
+2,500
New +$306K
WFC icon
281
Wells Fargo
WFC
$264B
$291K 0.05%
4,792
GILD icon
282
Gilead Sciences
GILD
$165B
$287K 0.04%
4,000
GSK icon
283
GSK
GSK
$106B
$280K 0.04%
6,320
-800
-11% -$37K
SMG icon
284
ScottsMiracle-Gro
SMG
$3.66B
$278K 0.04%
+2,600
New +$260K
IQV icon
285
IQVIA
IQV
$39.3B
$277K 0.04%
2,831
+85
+3% +$8.65K
TTEK icon
286
Tetra Tech
TTEK
$9.07B
$274K 0.04%
28,500
GNTX icon
287
Gentex
GNTX
$5.07B
$268K 0.04%
12,800
INDA icon
288
iShares MSCI India ETF
INDA
$6.63B
$268K 0.04%
7,425
+1,000
+16% +$34.8K
IWM icon
289
iShares Russell 2000 ETF
IWM
$83B
$268K 0.04%
1,755
-100
-5% -$15K
CLX icon
290
Clorox
CLX
$12.7B
$250K 0.04%
1,680
GDX icon
291
VanEck Gold Miners ETF
GDX
$27.4B
$249K 0.04%
10,700
UL icon
292
Unilever
UL
$136B
$249K 0.04%
4,000
AOS icon
293
A.O. Smith
AOS
$8.7B
$245K 0.04%
+4,000
New +$243K
QCOM icon
294
Qualcomm
QCOM
$176B
$243K 0.04%
3,800
-1,000
-21% -$60.6K
TRI icon
295
Thomson Reuters
TRI
$44.1B
$240K 0.04%
4,739
WM icon
296
Waste Management
WM
$91B
$239K 0.04%
2,765
PNR icon
297
Pentair
PNR
$11B
$234K 0.04%
4,938
RSG icon
298
Republic Services
RSG
$65.7B
$234K 0.04%
3,455
DOV icon
299
Dover
DOV
$28.4B
$232K 0.04%
2,847
IWF icon
300
iShares Russell 1000 Growth ETF
IWF
$128B
$231K 0.04%
6,864

Similar funds

Wellington Shields Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Wellington Shields Capital Management held 362 positions worth $644M, up 5.8% from $609M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Wellington Shields Capital Management's Q4 2017 filing shows 41 new, 85 increased, 99 reduced and 31 closed positions. Its largest new stake was AES: 156,250 shares worth $1.69M. The largest sale was Snyders-Lance, Inc., an estimated $2.23M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Technology.

  • Wellington Shields Capital Management's largest Q4 2017 buy was AES: 156,250 shares worth $1.69M.
  • Wellington Shields Capital Management added most to CVS Health in Q4 2017, an estimated $2.37M increase.
  • Wellington Shields Capital Management's biggest Q4 2017 reduction was Snyders-Lance, Inc., cutting an estimated $2.23M.
  • Wellington Shields Capital Management fully exited Gigamon Inc. in Q4 2017, selling an estimated $1.3M.
  • Wellington Shields Capital Management's ten largest holdings make up 36% of its $644M portfolio in Q4 2017.
  • Wellington Shields Capital Management opened 41 new positions and closed 31 in Q4 2017.
  • Wellington Shields Capital Management's portfolio value rose 5.8% quarter-over-quarter to $644M.

Based on Wellington Shields Capital Management's 13F filing for Q4 2017, filed 6 Feb 2018.